Explore more publications!
Health Watch Italy
Got News to Share?

Press Releases

Chamelo Debuts Lion City: First Smart Eyewear Crafted from Italian Acetate with Prescription-Ready Design at MIDO 2026
Jan. 31, 2026

Chamelo Debuts Lion City: First Smart Eyewear Crafted from Italian Acetate with Prescription-Ready Design at MIDO 2026

Indeterminate GlobeNewswire, Inc.
Petrochemical Market Size Projected to Surpass USD 1.25 Trillion by 2035 on Rising Demand from Construction and Automotive Sectors
6 hours ago

Petrochemical Market Size Projected to Surpass USD 1.25 Trillion by 2035 on Rising Demand from Construction and Automotive Sectors

Indeterminate GlobeNewswire, Inc.
Tower Semiconductor Teams with NVIDIA to Advance AI Infrastructure with 1.6T Data Center Optical Modules
3 hours ago

Tower Semiconductor Teams with NVIDIA to Advance AI Infrastructure with 1.6T Data Center Optical Modules

Indeterminate GlobeNewswire, Inc.
Conversational AI Market Outlook : Technological Advancements, Investment Opportunities & Global Dynamics | IBM, Google
3 hours ago

Conversational AI Market Outlook : Technological Advancements, Investment Opportunities & Global Dynamics | IBM, Google

Neutral EIN Presswire
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU
Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

Indeterminate GlobeNewswire, Inc.
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU
Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU

Indeterminate GlobeNewswire, Inc.
Althera and Bruno Farmaceutici Sign Strategic Licensing Agreement to Bring Advanced Type 2 Diabetes Therapy to Italy
Jan. 30, 2026

Althera and Bruno Farmaceutici Sign Strategic Licensing Agreement to Bring Advanced Type 2 Diabetes Therapy to Italy

Neutral EIN Presswire
Advanced Recycled Materials (ARM) in Packaging Market Trends 2026-35
7 hours ago

Advanced Recycled Materials (ARM) in Packaging Market Trends 2026-35

Indeterminate GlobeNewswire, Inc.
OMEICOS Therapeutics Announces Positive Phase 2 Study Outcome Demonstrating OMT-28’s Potential in Primary Mitochondrial Diseases (PMD)
Jan. 29, 2026

OMEICOS Therapeutics Announces Positive Phase 2 Study Outcome Demonstrating OMT-28’s Potential in Primary Mitochondrial Diseases (PMD)

Indeterminate GlobeNewswire, Inc.
Chronic and Acute Pain Clinical Trial Pipeline Analysis: 150+ Key Companies Shaping the Future of Chronic and Acute Pain Therapeutics | DelveInsight
Jan. 28, 2026

Chronic and Acute Pain Clinical Trial Pipeline Analysis: 150+ Key Companies Shaping the Future of Chronic and Acute Pain Therapeutics | DelveInsight

Indeterminate GlobeNewswire, Inc.
Fillings & Toppings Market US$41.9Bn by 2033 Driven by Bakery and Convenience Demand
8 hours ago

Fillings & Toppings Market US$41.9Bn by 2033 Driven by Bakery and Convenience Demand

Neutral EIN Presswire
Coastal Glo Med Spa Med Spa Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
Jan. 27, 2026

Coastal Glo Med Spa Med Spa Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health

Neutral EIN Presswire
Evestia Clinical Acquires ICRC-Weyer to Enhance Global Full-Service Clinical Research Capabilities
Jan. 27, 2026

Evestia Clinical Acquires ICRC-Weyer to Enhance Global Full-Service Clinical Research Capabilities

Indeterminate GlobeNewswire, Inc.
Natural Carotenoids Market Expected to Reach USD 708.03 Million by 2035 Amid Rising Functional Nutrition Trends
Jan. 27, 2026

Natural Carotenoids Market Expected to Reach USD 708.03 Million by 2035 Amid Rising Functional Nutrition Trends

Indeterminate GlobeNewswire, Inc.
Italy Debuts at SPIE Photonics West 2026 as Its Photonics Sector Tops €1 Billion at Home
Jan. 22, 2026

Italy Debuts at SPIE Photonics West 2026 as Its Photonics Sector Tops €1 Billion at Home

Neutral EIN Presswire
Pharmaceutical Packaging Laminates Market Trends for 2026
Jan. 21, 2026

Pharmaceutical Packaging Laminates Market Trends for 2026

Indeterminate GlobeNewswire, Inc.
Turkey overtakes Italy in production of olives, olive oil
Jan. 24, 2026

Turkey overtakes Italy in production of olives, olive oil

Indeterminate MENAFN
Owner: Sawsan Dababneh & Ramzi AbdelJaber

MENAFN

Indeterminate
Owned By Sawsan Dababneh & Ramzi AbdelJaber through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Amman, New York, Dubai

We welcome your feedback!
If you have comments or corrections, let us know.

Sustainable Innovation & Health Dividend Fund Distributions
Jan. 23, 2026

Sustainable Innovation & Health Dividend Fund Distributions

Indeterminate GlobeNewswire, Inc.
Middlefield Healthcare Dividend ETF Distributions
Jan. 23, 2026

Middlefield Healthcare Dividend ETF Distributions

Indeterminate GlobeNewswire, Inc.
Pouch Materials for Pharmaceutical Market Trends 2025-35
Jan. 23, 2026

Pouch Materials for Pharmaceutical Market Trends 2025-35

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions